申请人:Pfizer Inc.
公开号:US04246263A1
公开(公告)日:1981-01-20
A series of 4-(2-hydroxyethylthiomethyl)pyridines and related compounds, and their pharmaceutically acceptable acid addition salts, having antiinflammatory and immunoregulatory activity are disclosed. Preferred compounds include 4-(2-hydroxyethylthiomethyl)pyridine itself, as well as 4-(2-hydroxyphenylthiomethyl)pyridine, 4-(2-hydroxy-1-propylthiomethyl)pyridine, 4-(3-hydroxy-2-butylthiomethyl)pyridine, 4-(2-hydroxyethylthiomethyl)pyrimidine, the acetate esters corresponding to the above compounds, and 4-(2,3-dihydroxy-1-propylthiomethyl)pyridine.
揭示了一系列4-(2-羟乙基硫甲基)吡啶和相关化合物,以及它们的药用可接受的酸盐,具有抗炎和免疫调节活性。首选化合物包括4-(2-羟乙基硫甲基)吡啶本身,以及4-(2-羟基苯硫甲基)吡啶,4-(2-羟基-1-丙基硫甲基)吡啶,4-(3-羟基-2-丁基硫甲基)吡啶,4-(2-羟乙基硫甲基)嘧啶,与上述化合物对应的乙酸酯,以及4-(2,3-二羟基-1-丙基硫甲基)吡啶。